Patents by Inventor Noemi Csaba

Noemi Csaba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMERS FOR GENE THERAPY
    Publication number: 20230383064
    Abstract: Polymers for gene therapy. The present invention relates to a polymer, more specifically a polyphosphazene polymer, that is useful for gene therapy. The invention also relates to a complex comprising the polymer, the method for producing same and uses thereof.
    Type: Application
    Filed: October 22, 2021
    Publication date: November 30, 2023
    Inventors: Carla Maria GARCIA MAZAS, Noemi CSABA, Marcos GARCIA FUERTES
  • PURIFIED POLLEN PARTICLES AND USE THEREOF FOR ADMINISTERING NANOSYSTEMS
    Publication number: 20200129575
    Abstract: The present invention relates to a purified pollen particle that retains its intine and of exine layer and comprises nanosystems, to compositions including same, and to uses thereof.
    Type: Application
    Filed: February 8, 2018
    Publication date: April 30, 2020
    Inventors: Noemi CSABA, Diego PAN DELGADO, Sonia REIMONDEZ TROITIÑO, Marcos GARCÍA FUENTES
  • Nanocapsules of protamine
    Patent number: 9642816
    Abstract: The present invention relates to the design and development of nanocapsule systems for the administration of active substances, wherein the nanocapsules of the system have a mean diameter less than 1 ?m and are characterized by comprising (a) a protamine shell, (b) an oily core, and one or more surfactants characterized by having a hydrophilic-lipophilic ratio greater than 8, provided that said surfactant is not a phospholipid.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: May 9, 2017
    Assignee: Universidade de Santiago de Compostela
    Inventors: María José Alonso Fernández, Noemi Csaba, José Vicente González Aramundiz
  • NANOCAPSULAR FORMULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS
    Publication number: 20170087096
    Abstract: Nanocapsule systems of at least one active pharmaceutical ingredient selected from the group consisting of at least one insulin, insulin analogue, insulin derivative, glucagon-like peptide-1 receptor agonist (GLP1 R agonist) and/or dual GLP-1 receptor/glucagon receptor agonist and/or or any combination thereof are disclosed.
    Type: Application
    Filed: June 12, 2015
    Publication date: March 30, 2017
    Inventors: Gudrun Lenherr, Noemi Csaba, Nomceba Lungile Thwala, Zhigao Niu, Maria José Alonso
  • NANOCAPSULES OF PROTAMINE
    Publication number: 20160038433
    Abstract: The present invention relates to the design and development of nanocapsule systems for the administration of active substances, wherein the nanocapsules of the system have a mean diameter less than 1 ?m and are characterized by comprising (a) a protamine shell, (b) an oily core, and one or more surfactants characterized by having a hydrophilic-lipophilic ratio greater than 8, provided that said surfactant is not a phospholipid.
    Type: Application
    Filed: December 17, 2013
    Publication date: February 11, 2016
    Inventors: María José Alonso Fernández, Noemi Csaba, José Vicente González Aramundiz
  • Nanoparticles Of Chitosan And Polyethyleneglycol As A System For The Administration Of Biologically-Active Molecules
    Publication number: 20080095810
    Abstract: The present invention relates to nanoparticle systems for the release of biologically active molecules formed by the chitosan polymer or its derivatives, chemically modified with polyethylene glycol and crosslinked with a crosslinking agent. These systems are especially useful for pharmaceutical compositions, vaccines and cosmetic formulations.
    Type: Application
    Filed: March 14, 2006
    Publication date: April 24, 2008
    Applicant: Advanced In Vitro Cell Technologies, S.L.
    Inventors: Ma Alonso Fernandez, Kevin Janes, Noemi Csaba
  • Nanoparticles of polypoxyethylenated derivatives
    Publication number: 20060153923
    Abstract: The invention relates to nanoparticles of polyoxyethylenated derivatives, having a size of less than 1 micrometer, for the administration of pharmaceutically- or cosmetically-active ingredients. The inventive nanoparticles comprise a biodegradable polymer, a polyoxyethylene-derived block copolymer and at least one pharmaceutically- or cosmetically-active ingredient. The invention further relates to the method of obtaining the aforementioned nanoparticles and to compositions containing same.
    Type: Application
    Filed: June 17, 2004
    Publication date: July 13, 2006
    Inventors: Maria Jose Fernandez, Alejandro Barreiro, Noemi Csaba